Table 2.
Substance-related variables of study participants and correlation with barriers to treatment
| Parameters | Percentage | Fear of treatment, n (%) | Time conflict, n (%) | Admission difficulty, n (%) | Poor treatment availability, n (%) | Privacy concern, n (%) | Absence of problem, n (%) | Negative social support, n (%) |
|---|---|---|---|---|---|---|---|---|
| Total | 136 (68) | 199 (99.5) | 70 (35) | 69 (34.5) | 81 (40.5) | 161 (80.5) | 98 (49) | |
| Substance use type | ||||||||
| Alcohol (n=97) | 48.5 | 70 (72.2) | 97 (100) | 26 (26.8) | 26 (26.8) | 32 (33) | 84 (86.6) | 51 (52.6) |
| P | 0.220 | 0.331 | 0.018* | 0.026* | 0.036* | 0.035* | 0.326 | |
| Nicotine (n=121) | 60.5 | 80 (66.1) | 121 (100) | 47 (38.8) | 45 (37.2) | 51 (42.1) | 100 (82.6) | 60 (49.6) |
| P | 0.480 | 0.215 | 0.158 | 0.322 | 0.557 | 0.343 | 0.837 | |
| Others (n=23) | 11.5 | 13 (59.1) | 22 (100) | 10 (45.5) | 10 (45.5) | 13 (59.1) | 11 (50) | 8 (36.4) |
| P | 0.342 | 0.725 | 0.276 | 0.252 | 0.06 | 0.00001* | 0.209 | |
| Duration of SUD (months) | ||||||||
| <6 (n=38) | 19 | 35 (92.1) | 38 (100) | 10 (26.3) | 9 (23.7) | 14 (36.8) | 34 (89.5) | 14 (36.8) |
| >6 (n=162) | 81 | 101 (62.3) | 161 (99.4) | 60 (37) | 60 (37) | 67 (41.4) | 127 (78.4) | 84 (51.9) |
| P | 0.0001* | 0.627 | 0.212 | 0.119 | 0.610 | 0.121 | 0.096 | |
| Severity | ||||||||
| Mild (n=74) | 37 | 55 (74.3) | 74 (100) | 35 (47.3) | 34 (45.9) | 35 (47.3) | 59 (79.7) | 29 (39.2) |
| Moderate (n=94) | 47 | 58 (61.7) | 93 (98.9) | 28 (29.8) | 28 (29.8) | 35 (37.2) | 72 (76.6) | 54 (57.4) |
| Severe (n=32) | 16 | 23 (71.9) | 32 (100) | 7 (21.9) | 7 (21.9) | 11 (34.4) | 30 (93.8) | 15 (46.9) |
| P | 0.193 | 0.587 | 0.015* | 0.024* | 0.311 | 0.104 | 0.061 | |
| Past history of seeking treatment | ||||||||
| Present (n=50) | 25 | 39 (78) | 49 (98) | 18 (36) | 20 (40) | 26 (52) | 18 (36) | 26 (52) |
| Absent (n=150) | 75 | 97 (64.7) | 150 (100) | 52 (34.7) | 49 (32.7) | 55 (36.7) | 143 (95.3) | 72 (48) |
| P | 0.080 | 0.705 | 0.864 | 0.345 | 0.056 | 0.001* | 0.624 |
SUD Substance use disorder. *Significant at P < 0.05